Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Pfizer Stock Climbs With Positive Renal Cancer Phase III Data July 8, 2016 Takeda Splits Off a Range of Businesses to Focus on R&D April 6, 2017 Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal December 26, 2017
